Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|August 18, 2019
Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?Nathalie Van den Berghe, Ann Gils, Debby ThomasJournal of Gastroenterology and Hepatology|December 28, 2018
Immunogenicity is not the driving force of treatment failure in vedolizumab-treated inflammatory bowel disease patientsNathalie Van den Berghe, Bram Verstockt, Sophie Tops, et al.Therapeutic Advances in Gastroenterology|September 1, 2023
Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's diseaseNathalie Van den Berghe, Dahham Alsoud, Bram Verstockt, et al.Journal of Visualized Experiments : Jove|October 28, 2024
Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain ReactionNathalie Van den Berghe, Elien Costermans, Samir Nuseibeh, et al.Journal of Crohn'S & Colitis|November 27, 2020
Tissue Exposure does not Explain Non-Response in Ulcerative Colitis Patients with Adequate Serum Vedolizumab ConcentrationsNathalie Van den Berghe, Bram Verstockt, Ann Gils, et al.Journal of Pharmaceutical and Biomedical Analysis|March 11, 2020
Evaluating an easy sampling method using dried blood spots to determine vedolizumab concentrationsSumin Bian, Nathalie Van den Berghe, Liesbeth Vandersmissen, et al.Journal of Pharmaceutical and Biomedical Analysis|July 3, 2020
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasisNathalie Van den Berghe, Aurélie Truffot, Miet Peeters, et al.Journal of Crohn'S & Colitis|February 5, 2019
Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission RatesBram Verstockt, Erwin Dreesen, Maja Noman, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2019
Regulatory Role for NK Cells in a Mouse Model of Systemic Juvenile Idiopathic ArthritisJessica Vandenhaute, Anneleen Avau, Jessica Filtjens, et al.Iscience|July 11, 2022
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelMaya Imbrechts, Wim Maes, Louanne Ampofo, et al.Pageof 1